Cite
HARVARD Citation
Salvini, M. et al. (2017). Management of adverse events induced by next-generation immunomodulatory drug and proteasome inhibitors in multiple myeloma. Expert review of anticancer therapy. 17 (1), pp. 75-87. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Salvini, M. et al. (2017). Management of adverse events induced by next-generation immunomodulatory drug and proteasome inhibitors in multiple myeloma. Expert review of anticancer therapy. 17 (1), pp. 75-87. [Online].